These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8345564)

  • 21. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).
    Kadir A; Ali BH; al Hadrami G; Bashir AK; Landoni MF; Lees P
    J Vet Pharmacol Ther; 1997 Feb; 20(1):54-60. PubMed ID: 9049950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
    Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
    J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, tissue residue and plasma protein binding of ofloxacin in goats.
    Baruah H; Roy DC; Roy RK; Khonikor HN
    J Vet Sci; 2004 Jun; 5(2):97-101. PubMed ID: 15192335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylbutazone in the horse: a review.
    Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses.
    Zaghloul IY; Bedenice D; Ceresia ML; Jones PH; Sanchez-Londono A; Lobo MN; Böhlke M; Paradis MR
    Am J Vet Res; 2024 Jun; ():1-8. PubMed ID: 38942059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of phenylbutazone in plasma and milk of lactating dairy cows.
    De Veau EJ; Pedersoli W; Cullison R; Baker J
    J Vet Pharmacol Ther; 1998 Dec; 21(6):437-43. PubMed ID: 9885966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of difloxacin in goats.
    Atef M; el-Banna HA; Abd El-Aty AM; Goudah A
    Dtsch Tierarztl Wochenschr; 2002 Jul; 109(7):320-3. PubMed ID: 12161971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interactions between repeated dose phenylbutazone and gentamicin in the horse.
    Whittem T; Firth EC; Hodge H; Turner K
    J Vet Pharmacol Ther; 1996 Dec; 19(6):454-9. PubMed ID: 8971674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
    Carroll GL; Hooper RN; Boothe DM; Hartsfield SM; Randoll LA
    Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dose on the intravenous pharmacokinetics of tolfenamic acid in goats.
    Tekeli IO; Turk E; Durna Corum D; Corum O; Kirgiz FC; Uney K
    J Vet Pharmacol Ther; 2020 Sep; 43(5):435-439. PubMed ID: 32743801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.